Gene therapy for heart failure: The end of the beginning?


Next in Genetics and Epigenetics

Researchers believe Heart Disease could be reversed by introducing a gene into heart cells which would boost the production of a key protein and allow the muscle to recover.

Sian Harding is Professor of Cardiac Pharmacology at the National Heart and Lung Institute, Imperial College, as well as Institute Lead for Women for Athena Swan, and a co-investigator within the UKRMP Immunomodulation Hub.

Image courtesy of interviewee. October 18, 2017

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month. Login to view 8000+ figures on the platform.
Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.
error: